Executive News Wire

Fact-first intelligence synthesized across 12+ news agencies. Zero sensationalism.

Live Wire

CHRONOLOGICAL WIRE DISPATCHES

The NCRBuzz Standard

Every story is structurally partitioned: The News (pure facts), Key Takeaways, Historical Context, and Wire Attribution. Fact-first synthesis without sensationalism.

Aggregated from 12+ Wires Fact-Cross-Referenced

❤️ Support Bias-Free News

Help keep NCRBuzz 100% free of sensationalism, sponsored propaganda, and clickbait. Support our journalists via Google Reader Revenue.

Business & Stocks Economic Times Markets • Oct 09, 2026

Anthem Biosciences Block Deal: Portsmouth Technologies Offloads 30 Lakh Shares Worth Rs 250 Crore

💡 Key Takeaways

•Portsmouth Technologies LLC sold 30 lakh shares of Anthem Biosciences in a block deal worth Rs 249.90 crore.
•The transaction was executed at a fixed price of Rs 833 per share on October 9.
•The block deal coincides with Anthem Biosciences reporting a contraction in total income and profit after tax for Q1 FY27.

NEW DELHI [NCRBuzz Wire] — **Portsmouth Technologies LLC executed a high-value block deal involving 30 lakh equity shares of Anthem Biosciences on October 9.** The transaction was completed at an execution price of Rs 833 per share, bringing the total aggregate transaction value to Rs 249.90 crore.

**Market analysts note that this strategic secondary market stake sale substantially recalibrates Portsmouth Technologies LLC's equity positioning within Anthem Biosciences.** The divestment comes at a time when the bio-manufacturing firm is navigating a nuanced macroeconomic climate, having recently disclosed contractionary metrics in its total income and profit after tax (PAT) figures during the first quarter of fiscal year 2027 (Q1 FY27).

### Transaction Metrics

| Metric / Aspect | Details |

|---|---|

| Seller Entity | Portsmouth Technologies LLC |

| Target Company | Anthem Biosciences |

| Shares Sold | 30,00,000 (30 Lakhs) |

| Execution Price | Rs 833 per share |

| Total Deal Value | Rs 249.90 Crore |

| Transaction Date | October 9 |

**Institutional investors and market participants are closely observing the trading volumes and subsequent share price consolidation on national bourses following the block deal.** Regulatory filings with SEBI and stock exchanges will provide further clarity on the residual shareholding patterns of institutional entities in Anthem Biosciences as the market adjusts to the increased public float.

NCRBuzz Wire Desk ✓ Verified Wire

AI-synthesized and fact-audited across multiple independent news agencies.

Editorial Standards • About NCRBuzz

🏛️ Background Context

Block deals on Indian stock exchanges are executed through a separate trading window for large volume transactions, minimizing price volatility on the main order book. Institutional stake sales in mid-cap life sciences and bio-manufacturing entities often reflect broader portfolio rebalancing strategies in response to quarterly financial performance shifts.

💡 Citizen & Commuter Quick Explainer (FAQ)

Q1: What was the total value and volume of the Anthem Biosciences block deal?

Portsmouth Technologies LLC sold 30 lakh shares at Rs 833 each, aggregating to Rs 249.90 crore on October 9.

Q2: How does this transaction impact Portsmouth Technologies' holdings?

The block deal significantly reduces Portsmouth Technologies LLC's estimated equity stake in Anthem Biosciences.

Q3: What is the recent financial context of Anthem Biosciences?

The block deal comes against the backdrop of Anthem Biosciences reporting a decline in total income and profit after tax for Q1 FY27.

Verified Wires: Economic Times Markets Original Wire Dispatch ↗

Link copied to clipboard

Executive News Wire

60-Sec Speed Wire

Article Headline

All Caught Up!